Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 154 No. 9 (2024)

Health status, functioning and risk profiles for secondary health conditions in adolescents and young adults with spina bifida: a cross-sectional study at time of transition

DOI
https://doi.org/10.57187/s.3836
Cite this as:
Swiss Med Wkly. 2024;154:3836
Published
04.09.2024

Summary

INTRODUCTION: The transition from paediatric to adult medical care is a critical period for adolescents with spina bifida, often marked by deteriorating health and functional status.

OBJECTIVES: To describe the health status and functioning of individuals with spina bifida at the time of transition from paediatric to adult care and to identify risk profiles for potentially modifiable secondary health conditions (urinary tract infections, pressure injuries, respiratory problems and obesity).

METHODS: Descriptive study of data (derived from medical records) from all adolescents and young adults with spina bifida aged 15–25 years who were referred to a single specialised spinal cord injury centre as part of the transition programme during the period from 1 September 2015 to 31 May 2022. Descriptive statistics were used to describe the study population and to analyse the frequency and co-occurrence of congenital and acquired secondary health conditions. The equality of proportions test was used to test the prevalence of secondary health conditions based on important personal and clinical characteristics.

RESULTS: We included 43 adolescents with spina bifida with a mean age of 18.4 years (SD 2.5); in 63% of them the neurological level was lumbar, and around 50% of them were wheelchair-dependent. The median Spinal Cord Injury Measure (SCIM) III score was 72 (IQR 61–89). The mean number of secondary health conditions at time of transition was 8.8. The most prevalent secondary health conditions were lower urinary tract dysfunction, bowel dysfunction, sexual dysfunction and contractures. Respiratory problems were more prevalent in females and in individuals with lower SCIM III scores, whereas no differences were observed in the prevalence of other modifiable secondary health conditions. Clustering of secondary health conditions was mainly seen for urinary tract infection + pressure injury and for urinary tract infection + pressure injury + obesity.

CONCLUSION: The prevalence of secondary health conditions among individuals with spina bifida at time of transition is alarmingly high and functional profiles underscore the need for supporting adolescents and young adults with daily medical issues. The study highlights the critical role of transition programmes and interdisciplinary follow-up care in preventing health problems and improving functioning and independence in everyday life.

References

  1. Dicianno BE, Kurowski BG, Yang JM, Chancellor MB, Bejjani GK, Fairman AD, et al. Rehabilitation and medical management of the adult with spina bifida. Am J Phys Med Rehabil. 2008 Dec;87(12):1027–50. doi: https://doi.org/10.1097/PHM.0b013e31818de070 DOI: https://doi.org/10.1097/PHM.0b013e31818de070
  2. Dolk H; EUROCAT Working Group. Prevalence of neural tube defects in 20 regions of Europe and the impact of prenatal diagnosis, 1980-1986. J Epidemiol Community Health. 1991 Mar;45(1):52–8. doi: https://doi.org/10.1136/jech.45.1.52 DOI: https://doi.org/10.1136/jech.45.1.52
  3. Mandiracioğlu A, Ulman I, Lüleci E, Ulman C. The incidence and risk factors of neural tube defects in Izmir, Turkey: a nested case-control study. Turk J Pediatr. 2004;46(3):214–20.
  4. Schweizerisches Gesundheitsobservatorium. Angeborene Erkrankungen und Behinderungen. Nationaler Gesundheitsbericht 2020 2023; Available from: https://www.gesundheitsbericht.ch/de/06-chronische-krankheit-und-behinderung/67-angeborene-erkrankungen-und-behinderungen.html
  5. Campbell F, Biggs K, Aldiss SK, O’Neill PM, Clowes M, McDonagh J, et al. Transition of care for adolescents from paediatric services to adult health services. Cochrane Database Syst Rev. 2016 Apr;4(4):CD009794. doi: https://doi.org/10.1002/14651858.CD009794.pub2 DOI: https://doi.org/10.1002/14651858.CD009794.pub2
  6. Atta CA, Fiest KM, Frolkis AD, Jette N, Pringsheim T, St Germaine-Smith C, et al. Global Birth Prevalence of Spina Bifida by Folic Acid Fortification Status: A Systematic Review and Meta-Analysis. Am J Public Health. 2016 Jan;106(1):e24–34. doi: https://doi.org/10.2105/AJPH.2015.302902 DOI: https://doi.org/10.2105/AJPH.2015.302902
  7. Davis BE, Daley CM, Shurtleff DB, Duguay S, Seidel K, Loeser JD, et al. Long-term survival of individuals with myelomeningocele. Pediatr Neurosurg. 2005;41(4):186–91. doi: https://doi.org/10.1159/000086559 DOI: https://doi.org/10.1159/000086559
  8. Au KS, Ashley-Koch A, Northrup H. Epidemiologic and genetic aspects of spina bifida and other neural tube defects. Dev Disabil Res Rev. 2010;16(1):6–15. doi: https://doi.org/10.1002/ddrr.93 DOI: https://doi.org/10.1002/ddrr.93
  9. Wong LY, Paulozzi LJ. Survival of infants with spina bifida: a population study, 1979-94. Paediatr Perinat Epidemiol. 2001 Oct;15(4):374–8. doi: https://doi.org/10.1046/j.1365-3016.2001.00371.x DOI: https://doi.org/10.1046/j.1365-3016.2001.00371.x
  10. Shurtleff DB, Hayden PW, Chapman WH, Broy AB, Hill ML. Myelodysplasia. Problems of long-term survival and social function. West J Med. 1975 Mar;122(3):199–205.
  11. Pruitt LJ. Living with spina bifida: a historical perspective. Pediatrics. 2012 Aug;130(2):181–3. doi: https://doi.org/10.1542/peds.2011-2935 DOI: https://doi.org/10.1542/peds.2011-2935
  12. Hunt, G.M., Non-Selective Intervention in Newborn Babies with Open Spina Bifida: The Outcome 30 Years on for the Complete Cohort. Eur J Pediatr Surg, 1999. 9(S 1): p. 5-8. doi: https://doi.org/10.1055/s-2008-1072302 DOI: https://doi.org/10.1055/s-2008-1072302
  13. Singhal B, Mathew KM. Factors affecting mortality and morbidity in adult spina bifida. Eur J Pediatr Surg. 1999 Dec;9(S 1 Suppl 1):31–2. doi: https://doi.org/10.1055/s-2008-1072310 DOI: https://doi.org/10.1055/s-2008-1072310
  14. McDonnell GV, McCann JP. Why do adults with spina bifida and hydrocephalus die? A clinic-based study. Eur J Pediatr Surg. 2000 Dec;10(S 1 Suppl 1):31–2. doi: https://doi.org/10.1055/s-2008-1072411 DOI: https://doi.org/10.1055/s-2008-1072411
  15. Bowman RM, McLone DG, Grant JA, Tomita T, Ito JA. Spina bifida outcome: a 25-year prospective. Pediatr Neurosurg. 2001 Mar;34(3):114–20. doi: https://doi.org/10.1159/000056005 DOI: https://doi.org/10.1159/000056005
  16. Oakeshott P, Hunt GM, Poulton A, Reid F. Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study. Dev Med Child Neurol. 2010 Aug;52(8):749–53. doi: https://doi.org/10.1111/j.1469-8749.2009.03543.x DOI: https://doi.org/10.1111/j.1469-8749.2009.03543.x
  17. Buzzell A, Chamberlain JD, Eriks-Hoogland I, Hug K, Jordan X, Schubert M, et al.; for the SwiSCI study group and the Swiss National Cohort. All-cause and cause-specific mortality following non-traumatic spinal cord injury: evidence from a population-based cohort study in Switzerland. Spinal Cord. 2020 Feb;58(2):157–64. doi: https://doi.org/10.1038/s41393-019-0361-6 DOI: https://doi.org/10.1038/s41393-019-0361-6
  18. Ahmad I, Granitsiotis P. Urological follow-up of adult spina bifida patients. Neurourol Urodyn. 2007;26(7):978–80. doi: https://doi.org/10.1002/nau.20447 DOI: https://doi.org/10.1002/nau.20447
  19. Müller T, Arbeiter K, Aufricht C. Renal function in meningomyelocele: risk factors, chronic renal failure, renal replacement therapy and transplantation. Curr Opin Urol. 2002 Nov;12(6):479–84. doi: https://doi.org/10.1097/00042307-200211000-00006 DOI: https://doi.org/10.1097/00042307-200211000-00006
  20. Kinsman SL, Doehring MC. The cost of preventable conditions in adults with spina bifida. Eur J Pediatr Surg. 1996 Dec;6(S 1 Suppl 1):17–20. doi: https://doi.org/10.1055/s-2008-1071031 DOI: https://doi.org/10.1055/s-2008-1071031
  21. Sawin KJ, Bellin MH, Roux G, Buran CF, Brei TJ. The experience of self-management in adolescent women with spina bifida. Rehabil Nurs. 2009;34(1):26–38. doi: https://doi.org/10.1002/j.2048-7940.2009.tb00245.x DOI: https://doi.org/10.1002/j.2048-7940.2009.tb00245.x
  22. Van Walleghem N, Macdonald CA, Dean HJ. Evaluation of a systems navigator model for transition from pediatric to adult care for young adults with type 1 diabetes. Diabetes Care. 2008 Aug;31(8):1529–30. doi: https://doi.org/10.2337/dc07-2247 DOI: https://doi.org/10.2337/dc07-2247
  23. Gesellschaft für Transitionsmedizin. S3-Leitlinie: Transition von der Pädiatrie in die Erwachsenenmedizin. 2021. https://register.awmf.org/assets/guidelines/186-001l_S3_Transition_Paediatrie_Erwachsenenmedizin_2021-04-verlaengert.pdf
  24. Ito JA, Stevenson E, Nehring W, Alpeter A, Grant J. A qualitative examination of adolescents and adults with myelomeningocele: their perspective. Eur J Pediatr Surg. 1997 Dec;7 Suppl 1:53–4.
  25. Starowicz J, Cassidy C, Brunton L. Health Concerns of Adolescents and Adults With Spina Bifida. Front Neurol. 2021 Nov;12:745814. doi: https://doi.org/10.3389/fneur.2021.745814 DOI: https://doi.org/10.3389/fneur.2021.745814
  26. Berliner Transitions Programm. Berliner TransitionsProgramm e.V. 2009 19.05.20]; Available from: https://www.btp-ev.de/berliner-transitionsprogramm-e-v/
  27. Eriks-Hoogland I, et al. S2k-Leitlinie Lebenslange Nachsorge für Menschen mit Querschnittlähmung. 2022. https://register.awmf.org/assets/guidelines/179-014l_S2k_Lebenslange-Nachsorge-fuer-Menschen-mit-Querschnittlaehmung_2022-12.pdf
  28. Kirshblum SC, Burns SP, Biering-Sorensen F, Donovan W, Graves DE, Jha A, et al. International standards for neurological classification of spinal cord injury (revised 2011). J Spinal Cord Med. 2011 Nov;34(6):535–46. doi: https://doi.org/10.1179/204577211X13207446293695 DOI: https://doi.org/10.1179/204577211X13207446293695
  29. Itzkovich M, Gelernter I, Biering-Sorensen F, Weeks C, Laramee MT, Craven BC, et al. The Spinal Cord Independence Measure (SCIM) version III: reliability and validity in a multi-center international study. Disabil Rehabil. 2007 Dec;29(24):1926–33. doi: https://doi.org/10.1080/09638280601046302 DOI: https://doi.org/10.1080/09638280601046302
  30. Bendt M, Gabrielsson H, Riedel D, Hagman G, Hultling C, Franzén E, et al. Adults with spina bifida: A cross-sectional study of health issues and living conditions. Brain Behav. 2020 Aug;10(8):e01736. doi: https://doi.org/10.1002/brb3.1736 DOI: https://doi.org/10.1002/brb3.1736
  31. Liu JS, Dong C, Vo AX, Dickmeyer LJ, Leung CL, Huang RA, et al. Obesity and anthropometry in spina bifida: what is the best measure. J Spinal Cord Med. 2018 Jan;41(1):55–62. doi: https://doi.org/10.1080/10790268.2016.1195071 DOI: https://doi.org/10.1080/10790268.2016.1195071
  32. Heyns A, Negrini S, Jansen K, Moens P, Schelfaut S, Peers K, et al. The Prevalence of Scoliosis in Spina Bifida Subpopulations: A Systematic Review. Am J Phys Med Rehabil. 2018 Nov;97(11):848–54. doi: https://doi.org/10.1097/PHM.0000000000000966 DOI: https://doi.org/10.1097/PHM.0000000000000966
  33. Dennis M, Landry SH, Barnes M, Fletcher JM. A model of neurocognitive function in spina bifida over the life span. J Int Neuropsychol Soc. 2006 Mar;12(2):285–96. doi: https://doi.org/10.1017/S1355617706060371 DOI: https://doi.org/10.1017/S1355617706060371
  34. Hampton LE, Fletcher JM, Cirino PT, Blaser S, Kramer LA, Drake J, et al. Hydrocephalus status in spina bifida: an evaluation of variations in neuropsychological outcomes. J Neurosurg Pediatr. 2011 Sep;8(3):289–98. doi: https://doi.org/10.3171/2011.6.PEDS10584 DOI: https://doi.org/10.3171/2011.6.PEDS10584
  35. Wetzel JS, Heaner DP, Gabel BC, Tubbs RS, Chern JJ. Clinical evaluation and surveillance imaging of children with myelomeningocele and shunted hydrocephalus: a follow-up study. J Neurosurg Pediatr. 2018 Oct;23(2):153–8. doi: https://doi.org/10.3171/2018.7.PEDS1826 DOI: https://doi.org/10.3171/2018.7.PEDS1826
  36. Hanna-Wakim RH, Ghanem ST, El Helou MW, Khafaja SA, Shaker RA, Hassan SA, et al. Epidemiology and characteristics of urinary tract infections in children and adolescents. Front Cell Infect Microbiol. 2015 May;5:45. doi: https://doi.org/10.3389/fcimb.2015.00045 DOI: https://doi.org/10.3389/fcimb.2015.00045
  37. Zincir H, Kaya Erten Z, Ozkan F, Seviğ U, Başer M, Elmalı F. Prevalence of urinary tract infections and its risk factors in elementary school students. Urol Int. 2012;88(2):194–7. doi: https://doi.org/10.1159/000335554 DOI: https://doi.org/10.1159/000335554
  38. Stein, R., et al., Diagnostik und Therapie der neurogenen Blasenfunktionsstörungen bei Kindern und Jugendlichen mit spinaler Dysraphie. S2k Leitlinie 043-047. 2013.
  39. Tradewell M, Pariser JJ, Nimeh T, Elliott SP; Neurogenic Bladder Research Group. Systematic review and practice policy statements on urinary tract infection prevention in adults with spina bifida. Transl Androl Urol. 2018 May;7(S2 Suppl 2):S205–19. doi: https://doi.org/10.21037/tau.2018.04.21 DOI: https://doi.org/10.21037/tau.2018.04.21
  40. Spina Bifida Association. Guidelines for the Care of People with Spina Bifida. 2020 10.06.20]; Available from: https://www.spinabifidaassociation.org/guidelines/
  41. Valido E, Bertolo A, Fränkl GP, Itodo OA, Pinheiro T, Pannek J, et al. Systematic review of the changes in the microbiome following spinal cord injury: animal and human evidence. Spinal Cord. 2022 Apr;60(4):288–300. doi: https://doi.org/10.1038/s41393-021-00737-y DOI: https://doi.org/10.1038/s41393-021-00737-y

Most read articles by the same author(s)